Ovarian Cancer Subcommittee

Chair

Kathleen Moore, MD, MS

Vice Chair(s)

Joyce Liu, MD, MPH

New Investigator Liaisons

Peter Rose, MD

Working Groups

No active committee working groups.

Committee Charge

The NRG Oncology Ovarian Cancer Subcommittee’s purpose is to improve the lives of patients with ovarian cancer by designing and conducting practice-changing multi-institutional clinical trials and translational research. This committee focuses on developing and testing innovative advanced surgical, radiation oncology, and systemic (including chemotherapy, and other targeted / biologic therapies) technologies for patients with gynecologic ovarian malignancies. Additionally, the committee is committed to identifying and rectifying disparities in patient outcomes within this population.

The goals of this committee include developing national and international priorities, goals and initiatives for the management of ovarian cancer; developing and managing currently active and developing NRG clinical trials on the prevention, diagnosis and treatment of ovarian cancers; and, fostering the advancement of promising therapeutics in development and exploring potential translational research and biomarker development for incorporation into future clinical trials. This committee strives to develop and implement standardized procedures needed to design and conduct a research protocol within the NRG while identifying potential barriers and potential solutions to improve enrollment to NRG clinical trials in ovarian cancers, including fostering international collaboration. This committee meets four times a year, twice in-person and twice virtually.

Committee Members

TR Representatives

Rebecca Arend
Elizabeth Swisher

Core Members

Sarah Adams
Miriam AlHilli
Michael Birrer
Stephanie Blank
Michael Bookman
Justin Bottsford-Miller
Lindsay W. Brubaker
Yovanni Casablanca
Robert Coleman
Keiichi Fujiwara
Melissa Geller
Andrea Jewell
Tamara Kalir
Kidong Kim
Katherine Kurnit
Carrie Langstraat
Jayanthi Lea
Jung-Min Lee
Robin Lockhorst
Haider Mahdi
Gina Mantia-Smaldone
Merry Markham
Daniela Matei
Georgia McCann
Carolyn Muller
John Nakayama
Matthew Oliver
David O'Malley
Brian Orr
Kathryn Pennington
Leslie Randall
Debra Richardson
Sang Young Ryu
Angeles Alvarez Secord
Mark Shahin
Chrisann Winslow

General Members

Vaagn Andikyan
Kian Behbakht
Erin Bishop
Sara Bouberhan
Stephen H. Bush II
Guilherme Henrique Cantuaria
Michael Carney
John Chan
Deidre Cleary
Lauren Cobb
Amaranta Craig
Marta Crispens
Lauren Dockery
Nicole Eiseler
Tony Eng
Evelyn Fleming
Katherine Fuh
Anne Gabel
Whitney Graybill
Jean Hansen
Ellen Hartenbach
Nadia Ismiil
Eleftheria Kalogera
Michael Kelly
Byoung-Gie Kim
Charles Landen
Ying Liu
Colleen McCormick
Arwa Mohammad
Deborah Moore
Mark Morgan
Robert Morris
Mary Mullen
Christa Nagel
Matthew T Oliver
Brian Orr
Jeong-Yeol Park
Clarissa Polen-De
Rebecca L. Porter
Jianyu Rao
Maria Reyes
Colleen Rivard
John Schorge
William Tew
Diogo Torres
John Veena
Katrina Wade
Saravut Weroha
Ira Winer
Kristen Zeligs
Wenxin Zheng
Oliver Zivanovic
Emese Zsiros

Patient Representatives

Katheen Gavin

Alexi Wright

Nurse/DM Representatives

Mary Smrekar

Liz Swords

Support NRG Oncology.
Help Our Cause.

We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More

Donate Today

NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.